600079 ST人福医药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.06910.1567.67113.30717.753
总资产报酬率 ROA (%)1.5825.0663.6585.9106.955
投入资产回报率 ROIC (%)2.0436.5824.7757.8039.179

边际利润分析
销售毛利率 (%)49.53448.21444.55345.80643.525
营业利润率 (%)15.49113.3469.91514.05615.740
息税前利润/营业总收入 (%)17.07514.02110.90415.03916.398
净利润/营业总收入 (%)12.62110.4026.99211.47913.749

收益指标分析
经营活动净收益/利润总额(%)94.076108.568114.31391.83972.560
价值变动净收益/利润总额(%)2.3803.69310.14510.15525.656
营业外收支净额/利润总额(%)-0.525-4.626-4.094-1.872-2.626

偿债能力分析
流动比率 (X)1.9211.8331.4891.4851.283
速动比率 (X)1.6171.5351.2211.2111.057
资产负债率 (%)39.68440.11243.32044.48650.192
带息债务/全部投入资本 (%)29.50129.42032.33534.21940.188
股东权益/带息债务 (%)225.799226.129195.060179.446138.821
股东权益/负债合计 (%)130.090128.321111.435105.82383.166
利息保障倍数 (X)10.25611.0827.90812.11215.459

营运能力分析
应收账款周转天数 (天)145.063139.676122.512114.800115.106
存货周转天数 (天)98.449100.10791.70795.33893.421